• 1
    Petz LD, Garratty G. Warm antibody autoimmune hemolytic anemia. Corticosteroid therapy. In: Petz LD, Garratty G, editors.Immune Hemolytic Anemias. Philadelphia:Churchill Livingstone;2004. pp401407.
  • 2
    Murphy S, LoBuglio AF. Drug therapy of autoimmune hemolytic anemia. Semin Hematol 1976;13:323334.
  • 3
    Dameshek W, Komninos ZD. The present status of treatment of autoimmune hemolytic anemia with ACTH and cortisone. Blood 1956;11:648664.
  • 4
    Allgood JW, Chaplin HJr. Idiopathic acquired autoimmune hemolytic anemia. A review of forty-seven cases treated from 1955 through 1965. Am J Med 1967;43:254273.
  • 5
    Zupanska B, Sylwestrowicz T, Pawelski S. The results of prolonged treatment of autoimmune haemolytic anaemia. Haematologia (Budap) 1981;14:425433.
  • 6
    Engelfriet CP, Overbeeke MA, von dem Borne AE. Autoimmune hemolytic anemia. Semin Hematol 1992;29:312.
  • 7
    Roback JD, Barclay S, Hillyer CD. An automatable format for accurate immunohematology testing by flow cytometry. Transfusion 2003;43:918927.
  • 8
    Stroncek DF, Njoroge JM, Procter JL, et al. A preliminary comparison of flow cytometry and tube agglutination assays in detecting red blood cell-associated C3d. Transfus Med 2003;13:3541.
  • 9
    Gilliland BC. Coombs-negative immune hemolytic anemia. Semin Hematol 1976;13:267275.
  • 10
    Evans RS, Weiser RS. The serology of autoimmune hemolytic disease; observations on forty-one patients. AMA Arch Intern Med 1957;100:371399.
  • 11
    Worlledge SM, Blajchman MA. The autoimmune haemolytic anaemias. Br J Haematol 1972;23:6169.
  • 12
    Chaplin HJr. Clinical usefulness of specific antiglobulin reagents in autoimmune hemolytic anemias. Prog Hematol 1973;8:2549.
  • 13
    Issitt DP, Gutgseu NS. Clinically significant antibodies not detected by routine methods. In: Nance S, editor.Immune Destruction of Red Blood Cells. Arlington:American Association of Blood Banks;1989. pp9399.
  • 14
    Petz LD, Garratty G. Unusual aspects of acquired immune hemolytic anemias. A autoimmune hemolytic anemia with a negative direct antiglobulin test (DAT). In: Petz LD, Garratty G, editors.Immune Hemolytic Anemias. Philadelphia:Churchill Livingstone;2004. pp319334.
  • 15
    Jeje MO, Blajchman MA, Steeves K, et al. Quantitation of red cell-associated IgG using an immunoradiometric assay. Transfusion 1984;24:473476.
  • 16
    Kamesaki T, Oyamada T, Omine M, et al. Cut-off value of red-blood-cell-bound IgG for the diagnosis of Coombs-negative autoimmune hemolytic anemia. Am J Hematol 2009;84:98101.
  • 17
    Engelfriet CP, von dem Borne AEG, Beckers D, et al. Immune destruction of red cells. In: Bell CA, editor.A Seminar on Immune-Mediated Cell Destruction. Washington, DC:American Association of Blood Banks;1981. pp93130.
  • 18
    Zupanska B, Brojer E, Maslanka K, Hallberg T. A comparison between Fc receptors for IgG1 and IgG3 on human monocytes and lymphocytes using anti-Rh antibodies. Vox Sang 1985;49:6776.
  • 19
    Petz LD, Garratty G, editors.Acquired Immune Hemolytic Anemias, 1st ed. New York:Churchill Livingstone;1980.
  • 20
    Lechner K, Jäger U. How I treat autoimmune hemolytic anemias in adults. Blood 2010;116:18311838.
  • 21
    Toyotsuji T, Kamesaki T, Kajii E. Coombs-positive and negative autoimmune hemolytic anemia might immunologically differ. Rinsho Ketsueki (Japanese J Clin Hematol) 2011;52:461.
  • 22
    Petz LD, Garratty G. Prognosis and survival. Warm antibody AIHA. In: Petz LD, Garratty G, editors.Immune Hemolytic Anemias. Philadelphia:Churchill Livingstone;2004. pp7071.
  • 23
    Dausset J, Colombani J. The serology and the prognosis of 128 cases of autoimmune hemolytic anemia. Blood 1959;14:12801301.
  • 24
    Crosby WH, Rappaport H. Autoimmune hemolytic anemia. I. Analysis of hematologic observations with particular reference to their prognostic value; a survey of 57 cases. Blood 1957;12:4255.
  • 25
    Crosby WH. The clinical aspects of immunologic hemolytic anemia. Vox Sang 1955;26:36.
  • 26
    Nakasone H, Kako S, Endo H, et al. Diabetes mellitus is associated with high early-mortality and poor prognosis in patients with autoimmune hemolytic anemia. Hematology 2009;14:361365.